نتائج البحث - "Le Cesne, Axel"

1

Academic Journal

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

المؤلفون: Gounder, Mrinal M, Razak, Albiruni Abdul, Somaiah, Neeta, Chawla, Sant, Martin-Broto, Javier, Grignani, Giovanni, Schuetze, Scott M, Vincenzi, Bruno, Wagner, Andrew J, Chmielowski, Bartosz, Jones, Robin L, Riedel, Richard F, Stacchiotti, Silvia, Loggers, Elizabeth T, Ganjoo, Kristen N, Le Cesne, Axel, Italiano, Antoine, del Muro, Xavier Garcia, Burgess, Melissa, Piperno-Neumann, Sophie, Ryan, Christopher, Mulcahy, Mary F, Forscher, Charles, Penel, Nicolas, Okuno, Scott, Elias, Anthony, Hartner, Lee, Philip, Tony, Alcindor, Thierry, Kasper, Bernd, Reichardt, Peter, Lapeire, Lore, Blay, Jean-Yves, Chevreau, Christine, Morales, Claudia Maria Valverde, Schwartz, Gary K, Chen, James L, Deshpande, Hari, Davis, Elizabeth J, Nicholas, Garth, Gröschel, Stefan, Hatcher, Helen, Duffaud, Florence, Herráez, Antonio Casado, Beveridge, Roberto Diaz, Badalamenti, Giuseppe, Eriksson, Mikael, Meyer, Christian, von Mehren, Margaret, Van Tine, Brian A, Götze, Katharina, Mazzeo, Filomena, Yakobson, Alexander, Zick, Aviad, Lee, Alexander, Gonzalez, Anna Estival, Napolitano, Andrea, Dickson, Mark A, Michel, Dayana, Meng, Changting, Li, Lingling, Liu, Jianjun, Ben-Shahar, Osnat, Van Domelen, Dane R, Walker, Christopher J, Chang, Hua, Landesman, Yosef, Shah, Jatin J, Shacham, Sharon, Kauffman, Michael G, Attia, Steven

المصدر: Journal of Clinical Oncology. 40(22)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Genetics, Patient Safety, Clinical Research, 6.1 Pharmaceuticals, Cancer, Child, Double-Blind Method, Humans, Hydrazines, Liposarcoma, Triazoles, Oncology & Carcinogenesis, Oncology and carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/6ww9z65v
https://escholarship.org/content/qt6ww9z65v/qt6ww9z65v.pdf

View record in eScholarship

2

Academic Journal

Active surveillance in patients with extra-abdominal desmoid-type fibromatosis:a pooled analysis of three prospective observational studies

المؤلفون: Colombo, Chiara, Hakkesteegt, Stefanie, Le Cesne, Axel, Barretta, Francesco, Blay, Jean-Yves, Grünhagen, Dirk J, Penel, Nicolas, Lam, Laurent, Fiore, Marco, Palassini, Elena, Grignani, Giovanni, Tolomeo, Francesco, Collini, Paola, Merlini, Alessandra, Perrone, Federica, Stacchiotti, Silvia, Verhoef, Cornelis, Bonvalot, Sylvie, Gronchi, Alessandro

المصدر: Colombo , C , Hakkesteegt , S , Le Cesne , A , Barretta , F , Blay , J-Y , Grünhagen , D J , Penel , N , Lam , L , Fiore , M , Palassini , E , Grignani , G , Tolomeo , F , Collini , P , Merlini , A , Perrone , F , Stacchiotti , S , Verhoef , C , Bonvalot , S & Gronchi , A 2024 , ' Active surveillance in patients with extra-abdominal desmoid-type fibromatosis : a pooled analysis of three prospective observational studies ' , ....

وصف الملف: application/pdf

الاتاحة: https://pure.eur.nl/en/publications/5b1597e7-0827-4d19-a748-7fac78262f25
https://doi.org/10.1158/1078-0432.ccr-24-2340
https://pure.eur.nl/ws/files/180644752/Active_Surveillance_in_Patients_with_Extra-abdominal_Desmoid-Type_Fibromatosis.pdf

View record in BASE

3

Academic Journal

Replication Stress is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors

المساهمون: Programme ATIP - Avenir, Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Prédicteurs moléculaires et nouvelles cibles en oncologie (PMNCO), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, National Cancer Center Research Institute Tokyo, Génétique des génomes - Genetics of Genomes (UMR 3525), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Faculté de Médecine Paris-Saclay, Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Saclay, Institut Gustave Roussy (IGR), Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse (AMMICa), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), The institute of cancer research London, Institut de Génétique Moléculaire de Montpellier (IGMM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Stabilité génétique, cellules souches et radiations (SGCSR (U_1274 / UMR_E_008)), Institut de Radiobiologie Cellulaire et Moléculaire (IRCM), Université Paris-Saclay-Institut de Biologie François JACOB (JACOB), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Institut de Biologie François JACOB (JACOB), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), University College of London London (UCL), Merck Darmstadt, We thank patients andfamilies for their donations to the Gustave Roussy Sarcoma Tumor Board andResearch program, Gustave Roussy Sarcoma Donors, Association “Un élanpour Lucas” and Family L, whose donations have been instrumental in allowingus to pursue this project. AKK was funded by ESMO fellowship and donationsvia the Gustave Roussy Sarcoma Committee, CA was funded by a Fondationpour la Recherche Médicale (FRM) PhD fellowship (ECO202206015528), RMCreceived award funding from Association Ruban Rose, Fondation Bettencourt-Schueller, Institut Servier, Fondation des Treilles and Cancéropôle Ile-De-France.This work was also funded by programme grants to SPV from SociétéFrançaise Cancers Enfant / Imagine for Margo, Cancéropôle Ile-de-France (Recherche et Innovation en Cancérologie-RIC-01-IGR and 2017-1-EMERG-72), Fondation ARC (PGA1-RF20190208576), European ResearchCouncil ERC (TargetSWitch 101077864), INSERM ATIP-Avenir / La LigueContre le Cancer 2018, as well as programme grants to Gustave Roussy fromInstitut National du Cancer (INCa-DGOS-Inserm_12551 SIRIC2 and INCa-DGOS-Inserm-ITMO Cancer_18002 SIRIC EpiCURE).We also thank FIGHT KIDS CANCER (FKC) Representatives KickCancer,Imagine for Margo, Foundation Kriibskrank Kanner and CRIS CancerFoundation for awarding the 2024 FIGHT KIDS CANCER & St. Baldrick’sFoundation Arceci Innovation Award to SPV. The independent selectionKawai-Kawachi Targeting replication stress in DSRCT 42process of this Innovation Award, funded by FKC, was administered by the StBaldrick's Foundation.Work carried out in the lab of CJL was funded via a CRUK Programme Grant.RMC and SPV thank Dr. M Gary Bobo and Dr. L Ali for having performed someorthogonal validation experiments not included in the final manuscript.AL, ARM and JS thank the Kelly Turner Foundation, the Tom Bowdidge YouthCancer Foundation and RobsARTTT for their support., European Project: 101077864 ,ERC-2022-STG ,10.3030/101077864,TargetSWItch(2023)

المصدر: ISSN: 0008-5472.

مصطلحات موضوعية: PARP inhibitors, ATR inhibitors, EWS-WT1, replication stress, DSRCT, cGAS/STING, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/39412947; info:eu-repo/grantAgreement//101077864 /EU/Targeting SWI/SNF-related chromatin remodelling defects in solid tumours/TargetSWItch; PUBMED: 39412947

الاتاحة: https://hal.science/hal-04798508
https://hal.science/hal-04798508v1/document
https://hal.science/hal-04798508v1/file/Accepted%20Manuscript.pdf
https://doi.org/10.1158/0008-5472.CAN-23-3603

View record in BASE

4

Academic Journal

Vena cava leiomyosarcoma surgery results in a retrospective cohort of 41 patients from two centers

المؤلفون: Bertrand, Thibaud, Faron, Matthieu, Mercier, Olaf, Ngo, Carine, Le Pechoux, Cécile, Levy, Antonin, Issard, Justin, Henon, Clémence, Honoré, Charles, Fadel, Elie, Le Cesne, Axel

المساهمون: Institut Gustave Roussy (IGR), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Université Paris-Saclay, Hôpital Marie-Lannelongue, Radiothérapie Moléculaire et Innovation Thérapeutique (RaMo-IT), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay

المصدر: ISSN: 0022-4790.

مصطلحات موضوعية: inferior vena cava, leiomyosarcoma, LMS, outcomes, primary, prognostic, superior vena cava, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/38973131; PUBMED: 38973131

الاتاحة: https://hal.science/hal-04683795
https://hal.science/hal-04683795v1/document
https://hal.science/hal-04683795v1/file/Journal%20of%20Surgical%20Oncology%20-%202024%20-%20Bertrand%20-%20Vena%20cava%20leiomyosarcoma%20surgery%20results%20in%20a%20retrospective%20cohort%20of%2041.pdf
https://doi.org/10.1002/jso.27765

View record in BASE

5

Academic Journal

Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiated fields (SIF)

المؤلفون: Huchet, Noémie, Penel, Nicolas, Bonvalot, Sylvie, Thariat, Juliette, Ducimetière, Françoise, Giraud, Antoine, Toulmonde, Maud, Le Cesne, Axel, Blay, Jean-Yves, Bellera, Carine

المساهمون: Institut Bergonié Bordeaux, UNICANCER, Centre Régional de Lutte contre le Cancer Oscar Lambret Lille (UNICANCER/Lille), Université de Lille-UNICANCER, Departement de chirurgie Institut Curie, Institut Curie Paris, Laboratoire de physique corpusculaire de Caen (LPCC), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-École Nationale Supérieure d'Ingénieurs de Caen (ENSICAEN), Normandie Université (NU)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Centre Léon Bérard Lyon, Institut Gustave Roussy (IGR), Département de médecine oncologique Gustave Roussy, Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: ISSN: 1758-8340.

مصطلحات موضوعية: competing risks, irradiation, sarcoma, survival analysis, [PHYS]Physics [physics]

Relation: INSPIRE: 2752741

الاتاحة: https://hal.science/hal-04425867
https://hal.science/hal-04425867v1/document
https://hal.science/hal-04425867v1/file/handling-missing-covariates.pdf
https://doi.org/10.1177/17588359231220999

View record in BASE

6

Academic Journal

Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs

المساهمون: Prédicteurs moléculaires et nouvelles cibles en oncologie (PMNCO), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Département d’Innovation Thérapeutique et essais précoces Gustave Roussy (DITEP), Institut Gustave Roussy (IGR), Programme ATIP - Avenir, Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Unité de génétique et biologie des cancers (U830), Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Curie Paris, Département de biologie et pathologie médicales Gustave Roussy, Immunologie anti-tumorale et immunothérapie des cancers (ITIC), Département de cancérologie de l'enfant et de l'adolescent Gustave Roussy, Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse (AMMICa), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Département de médecine oncologique Gustave Roussy, University College of London London (UCL), The institute of cancer research London

المصدر: ISSN: 2666-3791 ; Cell Reports Medicine ; https://inserm.hal.science/inserm-04658391 ; Cell Reports Medicine, 2024, 5 (6), pp.101582. ⟨10.1016/j.xcrm.2024.101582⟩.

مصطلحات موضوعية: EWSR1::WT1, cancer-associated fibroblasts, desmoplastic small round cell tumor, microenvironment, molecular and cellular heterogeneity, plasticity, sarcoma, single-cell RNA-sequencing, spatial transcriptomics, transcription factor, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SHS.STAT]Humanities and Social Sciences/Methods and statistics, [STAT]Statistics [stat], [STAT.OT]Statistics [stat]/Other Statistics [stat.ML], [STAT.ME]Statistics [stat]/Methodology [stat.ME]

Relation: info:eu-repo/semantics/altIdentifier/pmid/38781959; PUBMED: 38781959; PUBMEDCENTRAL: PMC11228554

الاتاحة: https://inserm.hal.science/inserm-04658391
https://inserm.hal.science/inserm-04658391v1/document
https://inserm.hal.science/inserm-04658391v1/file/2024_Faron_CellRepMed.pdf
https://doi.org/10.1016/j.xcrm.2024.101582

View record in BASE

7

Academic Journal

Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosis.

المساهمون: Université de Lille, CHU Lille, Centre Léon Bérard Lyon, Centre Régional de Lutte contre le Cancer Oscar Lambret Lille UNICANCER/Lille, Institut Curie Paris, Institut Bergonié Bordeaux, Centre Hospitalier Lyon Sud CHU - HCL CHLS, Institut Claudius Regaud, Centre Hospitalier Universitaire Strasbourg CHU Strasbourg, Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen CLCC Henri Becquerel, Institut de Cancérologie de l'Ouest Angers/Nantes UNICANCER/ICO, Institut de Cancérologie de la Loire Lucien Neuwirth, Hôpital de la Timone CHU - APHM TIMONE, Institut Gustave Roussy IGR, Centre de recherche en épidémiologie et santé des populations CESP, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

مصطلحات موضوعية: desmoid-type fibromatosis, hormonal contraception, hormone-dependency tumor, outcome, pregnancy

وصف الملف: application/rdf+xml; charset=utf-8; application/pdf

Relation: European Society for Medical Oncology; ESMO Open; http://hdl.handle.net/20.500.12210/89986

الاتاحة: https://hdl.handle.net/20.500.12210/89986

View record in BASE

8

Academic Journal

Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCT.

المؤلفون: Spierenburg, G., Grimison, P., Chevreau, Christine, Stacchiotti, S., Piperno-Neumann, S., Le Cesne, Axel, Ferraresi, V., Italiano, A., Duffaud, Florence, Penel, Nicolas, Metzger, Severine, Chabaud, Sylvie, Van Der Heijden, L., Pérol, David, Van De Sande, M. A. J., Blay, Jean-Yves, Gelderblom, H.

المساهمون: Université de Lille, CHU Lille, Institut Universitaire du Cancer de Toulouse - Oncopole IUCT Oncopole - UMR 1037, Institut Gustave Roussy IGR, Hôpital de la Timone CHU - APHM TIMONE, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Centre Léon Bérard Lyon

مصطلحات موضوعية: TGCT, PVNS, Nilotinib, CSF1, CSF1R inhibitor, Tyrosine kinase inhibitor

وصف الملف: application/rdf+xml; charset=utf-8; application/pdf

Relation: European Journal of Cancer; Eur J Cancer; http://hdl.handle.net/20.500.12210/90018

الاتاحة: https://hdl.handle.net/20.500.12210/90018

View record in BASE

9

Academic Journal

Pain in desmoid-type fibromatosis: prevalence, determinants, and prognosis value.

المؤلفون: Penel, Nicolas, Bonvalot, Sylvie, Le Deley, Marie-Cécile, Italiano, Antoine, Tlemsani, Camille, Pannier, Diane, Leguillette, Clémence, Kurtz, Jean-Emmanuel, Toulmonde, Maud, Thery, Julien, Orbach, Daniel, Dubray-Longeras, Pascale, Verret, Benjamin, Bertucci, François, Guillemet, Cécile, Laroche, Lucie, Dufresne, Armelle, Blay, Jean-Yves, Le Cesne, Axel

المساهمون: Université de Lille, CHU Lille, Centre Régional de Lutte contre le Cancer Oscar Lambret Lille UNICANCER/Lille, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Institut Curie Paris, Centre Hospitalier Régional Universitaire CHU Lille CHRU Lille, Université de Versailles Saint-Quentin-en-Yvelines UVSQ, Institut Bergonié Bordeaux, Hôpital Cochin AP-HP, Centre Hospitalier Universitaire Strasbourg CHU Strasbourg, Centre Jean Perrin Clermont-Ferrand UNICANCER/CJP, Institut Gustave Roussy IGR, Institut Paoli-Calmettes IPC, Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen CLCC Henri Becquerel, Centre Léon Bérard Lyon

مصطلحات موضوعية: depression, Desmoid-type fibromatosis, outcome, pain, quality of life

وصف الملف: application/rdf+xml; charset=utf-8; application/pdf

Relation: International Journal of Cancer; Int J Cancer; http://hdl.handle.net/20.500.12210/89842

الاتاحة: https://hdl.handle.net/20.500.12210/89842

View record in BASE

10

Academic Journal

Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study.

المؤلفون: Brodowicz, Thomas, Liegl-Atzwanger, Bernadette, Penel, Nicolas, Mir, Olivier, Blay, Jean-Yves, Kashofer, Karl, Le Cesne, Axel, Decoupigny, Emilie, Wallet, Jennifer, Hamacher, Rainer, Le Deley, Marie-Cécile

المساهمون: Université de Lille, CHU Lille, Medizinische Universität Wien = Medical University of Vienna, Medical University of Graz, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Institut Gustave Roussy IGR, Centre Léon Bérard Lyon, Site de Recherche Intégrée en Cancérologie SIRIC-ONCOLille, Centre Hospitalier Régional Universitaire Lille CHRU Lille, West German Cancer Center Essen, Germany, Université Paris-Sud - Paris 11 UP11

مصطلحات موضوعية: regorafenib, biomarkers, sarcoma, soft tissue sarcoma, prognosis, multikinase inhibitor

وصف الملف: application/rdf+xml; charset=utf-8; application/pdf

Relation: Cancers; Cancers (Basel); http://hdl.handle.net/20.500.12210/90475

الاتاحة: https://hdl.handle.net/20.500.12210/90475

View record in BASE

11

Academic Journal

Updates on Chimeric Antigen Receptor T-Cells in Large B-Cell Lymphoma.

المؤلفون: Saleh, Khalil, Khalife, Nadine, Arbab, Ahmadreza, Khoury, Rita, Chahine, Claude, Ibrahim, Rebecca, Tikriti, Zamzam, Masri, Nohad, Hachem, Mohamad, Le Cesne, Axel

المصدر: Biomedicines; Dec2024, Vol. 12 Issue 12, p2810, 16p

مصطلحات موضوعية: CYTOKINE release syndrome, BISPECIFIC antibodies, CHIMERIC antigen receptors, T cells, DISEASE relapse

Full Text Finder

12

Academic Journal

Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials.

المؤلفون: Zoghbi, Marianne, Patel, Brina A., Roulleaux Dugage, Matthieu, Mezquita, Laura, Bahleda, Rastilav, Dufresne, Armelle, Brahmi, Mehdi, Ray-Coquard, Isabelle, Pautier, Patricia, Blay, Jean-Yves, Le Cesne, Axel, Massard, Christophe, Besse, Benjamin, Auclin, Edouard, Nassif Haddad, Elise F.

المصدر: Cancers; Dec2024, Vol. 16 Issue 23, p4053, 14p

مصطلحات جغرافية: FRANCE

Full Text Finder

13

Academic Journal

Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value

المؤلفون: Penel, Nicolas, Bonvalot, Sylvie, Le Deley, Marie Cécile, Italiano, Antoine, Tlemsani, Camille, Pannier, Diane, Leguillette, Clémence, Kurtz, Jean Emmanuel, Toulmonde, Maud, Thery, Julien, Orbach, Daniel H., Dubray-Longeras, Pascale, Verret, Benjamin, Bertucci, François, Guillemet, Cécile, Laroche, Lucie, Dufresne, Armelle, Blay, Jean Yves, Le Cesne, Axel L.

المساهمون: Centre Régional de Lutte contre le Cancer Oscar Lambret Lille (UNICANCER/Lille), Université de Lille-UNICANCER, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Institut Curie Paris, Université Paris Sciences et Lettres (PSL), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Institut Bergonié Bordeaux, UNICANCER, Hôpital Cochin AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Cité (UPCité), Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Centre Jean Perrin Clermont-Ferrand (UNICANCER/CJP), Institut Gustave Roussy (IGR), Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Centre Léon Bérard Lyon, Ligue Contre le Cancer: PRE2016.LCC/NP, Institut National Du Cancer, INCa, The authors would like to thank the patients and families for their participation in this study, the staff members involved in the trial management and data analysis, in particular Emilie Decoupigny André Michel Bimbaï and Marie Vanseymortier from the sponsorship unit at Centre Oscar Lambret, Lille, all the investigators and their teams who participated in the trial, the patient advocacy group “SOS Desmoïde,” Françoise Bonichon for her help in literature research and the data managers from Centre de Traitement des Données du Cancéropôle Nord-Ouest (CTD-CNO), who oversaw the trial data management, the CTD-CNO clinical research platform was funded by the French National Cancer Institute (INCa) and “La Ligue Nationale Contre le Cancer”., This work was supported by a personal grant from a donor (S. Wisnia), the Ligue Nationale Contre le Cancer (PRE2016.LCC/NP), Intersarc (funded by the French National Cancer Institute, INCA), APICIL Foundation and SOS Desmoïde. These funders had no role in the design, conduct or reporting of this work., The authors would like to thank the patients and families for their participation in this study, the staff members involved in the trial management and data analysis, in particular Emilie Decoupigny André Michel Bimbaï and Marie Vanseymortier from the sponsorship unit at Centre Oscar Lambret, Lille, all the investigators and their teams who participated in the trial, the patient advocacy group “SOS Desmoïde,” Françoise Bonichon for her help in literature research and the data managers from Centre de Traitement des Données du Cancéropôle Nord‐Ouest (CTD‐CNO), who oversaw the trial data management, the CTD‐CNO clinical research platform was funded by the French National Cancer Institute (INCa) and “La Ligue Nationale Contre le Cancer”.

المصدر: ISSN: 0020-7136.

مصطلحات موضوعية: depression, Desmoid-type fibromatosis, outcome, pain, quality of life, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/36883417; hal-04106296; https://hal.science/hal-04106296; https://hal.science/hal-04106296/document; https://hal.science/hal-04106296/file/Intl%20Journal%20of%20Cancer%20-%202023%20-%20Penel%20-%20Pain%20in%20desmoid%E2%80%90type%20fibromatosis%20%20Prevalence%20%20determinants%20and%20prognosis%20value.pdf; PUBMED: 36883417

الاتاحة: https://hal.science/hal-04106296
https://hal.science/hal-04106296/document
https://hal.science/hal-04106296/file/Intl%20Journal%20of%20Cancer%20-%202023%20-%20Penel%20-%20Pain%20in%20desmoid%E2%80%90type%20fibromatosis%20%20Prevalence%20%20determinants%20and%20prognosis%20value.pdf
https://doi.org/10.1002/ijc.34493

View record in BASE

14

Academic Journal

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma.

المساهمون: Université de Lille, CHU Lille, Centre de Physiopathologie de Toulouse-Purpan INSERM U563 - CNRS UMR1037, Institut Claudius Regaud, Centre de Recherches en Cancérologie de Toulouse CRCT, Centre Léon Bérard Lyon, UNICANCER - Institut régional du Cancer Montpellier Val d'Aurelle ICM, Institut de Cancérologie de l'Ouest Angers/Nantes UNICANCER/ICO, Institut Bergonié Bordeaux, Département d'oncologie médicale Centre Georges-François Leclerc, Centre Régional de Lutte contre le Cancer François Baclesse Caen UNICANCER/CRLC, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Cancérologie Inserm U599/IPC, Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen CLCC Henri Becquerel, Centre de recherche en épidémiologie et santé des populations CESP, Institut Gustave Roussy IGR

مصطلحات موضوعية: ABC transporters, advanced soft tissue sarcoma, CYP450, hepatotoxicity, next-generation sequencing, pharmacogenetic, trabectedin

وصف الملف: application/rdf+xml; charset=utf-8; application/pdf

Relation: Cancers; Cancers (Basel); http://hdl.handle.net/20.500.12210/90484

الاتاحة: https://hdl.handle.net/20.500.12210/90484

View record in BASE

15

Academic Journal

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA).

المساهمون: Université de Lille, CHU Lille, Institut Gustave Roussy IGR, Centre Hospitalier Régional Universitaire de Besançon CHRU Besançon, Centre Régional de Lutte contre le cancer Georges-François Leclerc Dijon UNICANCER/CRLCC-CGFL, Democritus University of Thrace DUTH, University of Minnesota, Centre Léon Bérard Lyon, Centre de Recherches en Cancérologie de Toulouse CRCT, CHU Trousseau Tours, Institut du Cancer de Montpellier ICM, CHU Estaing Clermont-Ferrand, Institut Paoli-Calmettes IPC, CRLCC René Gauducheau, Institut Curie Paris, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, McGill University = Université McGill Montréal, Canada, Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen CLCC Henri Becquerel, Hôpital de la Timone CHU - APHM TIMONE, Hôpitaux universitaires de Genève = University Hospitals of Geneva HUG

مصطلحات موضوعية: Sarcoma, Brain metastasis, Prognostic index

وصف الملف: application/rdf+xml; charset=utf-8; application/pdf

Relation: BMC Cancer; http://hdl.handle.net/20.500.12210/90698

الاتاحة: https://hdl.handle.net/20.500.12210/90698

View record in BASE

16

Academic Journal

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

المؤلفون: De Pinieux, Gonzague, Karanian, Marie, Le Loarer, Francois, Le Guellec, Sophie, Chabaud, Sylvie, Terrier, Philippe, Bouvier, Corinne, Batistella, Maxime, Neuville, Agnes, Robin, Yves-Marie, Emile, Jean-Francois, Moreau, Anne, Larousserie, Frederique, Leroux, Agnes, Stock, Nathalie, Lae, Marick, Collin, Francoise, Weinbreck, Nicolas, Aubert, Sebastien, Mishellany, Florence, Charon-Barra, Celine, Croce, Sabrina, Doucet, Laurent, Quintin-Rouet, Isabelle, Chateau, Marie-Christine, Bazille, Celine, Valo, Isabelle, Chetaille, Bruno, Ortonne, Nicolas, Brouchet, Anne, Rochaix, Philippe, Demuret, Anne, Ghnassia, Jean-Pierre, Mescam, Lenaig, Macagno, Nicolas, Birtwisle-Peyrottes, Isabelle, Delfour, Christophe, Angot, Emilie, Pommepuy, Isabelle, Ranchere, Dominique, Chemin-Airiau, Claire, Jean-Denis, Myriam, Fayet, Yohan, Courreges, Jean-Baptiste, Mesli, Nouria, Berchoud, Juliane, Toulmonde, Maud, Italiano, Antoine, Le Cesne, Axel, Penel, Nicolas, Ducimetiere, Francoise, Gouin, Francois, Coindre, Jean-Michel, Blay, Jean-Yves

المساهمون: CHU Lille, CNRS, ENSCL, INRA, INSERM, Université de Lille, Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192, Cancer Heterogeneity, Plasticity and Resistance to Therapies (CANTHER) - UMR 9020 - UMR 1277, Institut de Pathologie CHU Lille, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

مصطلحات موضوعية: Sarcoma, Metastatic tumors, Cancer epidemiology, Angiosarcoma, Neurological tumors, Skin tumors, Gastrointestinal cancers, Malignant tumors

وصف الملف: application/octet-stream

Relation: Institut François Rabelais pour la recherche multidisciplinaire sur le cancer; Development Cancer and Targeted Therapies; Clinical proof of concept of dependence receptor targeting in gynecological Oncology; PLoS ONE; http://hdl.handle.net/20.500.12210/75036

الاتاحة: https://hdl.handle.net/20.500.12210/75036

View record in BASE

17

Academic Journal

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma

المؤلفون: Dufresne, Armelle, Lesluyes, T., Menetrier-Caux, C., Brahmi, M., Darbo, E., Toulmonde, Maud, Italiano, A., Mir, O., Le Cesne, Axel, Le Guellec, S., Valentin, T., Chevreau, C., Bonvalot, S., Robin, Yves-Marie, Coindre, J.-M., Caux, C., Blay, J. Y., Chibon, F.

المساهمون: INSERM, Université de Lille, Centre Léon Bérard Lyon, Université de Bordeaux UB, Université Claude Bernard Lyon 1 UCBL, Institut Bergonié Bordeaux, Institut Claudius Regaud, Institut Gustave Roussy IGR, Institut Curie Paris, Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192

مصطلحات موضوعية: predictive factor, Soft tissue sarcoma, immunologic landscape, gene expression, histological diagnosis

وصف الملف: application/rdf+xml; charset=utf-8; application/octet-stream

Relation: Oncoimmunology; http://hdl.handle.net/20.500.12210/75172

الاتاحة: https://hdl.handle.net/20.500.12210/75172

View record in BASE